, ,

Catalent To Expand Wisconsin Biomanufacturing Operation

Biotechnology Company Plans To Add More Than 100 New Jobs At Facility In Southern Wisconsin


A biotechnology company plans to add more than 100 new jobs at its facility in southern Wisconsin.

The Wisconsin State Journal reports that New Jersey-based Catalent announced Monday a nearly $100 million investment to expand Catalent Biologics Madison over the next three years. The company develops and manufactures pharmaceutical products made from living cells instead of chemicals at the Madison facility.

Catalent announced a similar investment this week at its facility in Bloomington, Indiana.

Stay informed on the latest news

Sign up for WPR’s email newsletter.

This field is for validation purposes and should be left unchanged.

It will be the second expansion of operations at Catalent Biologics Madison in about two years.

Catalent Biologics spokesman Bernie Clark said the latest project will build a 60,000-square-foot addition at the Madison site. It’s expected to be complete by 2021.

Clark said the site is already hiring for dozens of open positions.